1. Medtech Insight
  2. >>Policy & Regulation

Medtronic’s Transcatheter Harmony Valve For Congenital Pulmonary Defect Wins FDA Approval

 
• By Elizabeth Orr

The Harmony transcatheter pulmonary valve can be used to improve blood flow to the lungs in patients with severe pulmonary valve regurgitation as a result of a congenital malformation of the right ventricular outflow tract.

A pair of adult-sized hands surround the hands of a child, which themselves hold a red toy heart with an EEG line design on it.
• Source: Shutterstock

A newly approved minimally invasive treatment for congenital heart defects could help up to 8,000 newborns per year, the US Food and Drug Administration announced on 26 March.

The agency approved a PMA for Medtronic’s Harmony transcatheter pulmonary valve (TPV) system in pediatric and adult patients . Harmony is intended to improve blood flow to the lungs in patients with severe pulmonary valve regurgitation

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Approvals

More from Policy & Regulation

Faster Device Certification Among Keys To Unlocking Innovation In EU MedTech Sector

 
• By Amanda Maxwell

While MedTech Europe sharpens its focus on what the EU most urgently needs to advance the medtech market in four targeted measures, the European Commission has also unveiled four priorities for 2025.

Beyond The Bladder: Incontinence Impacts Mental Health

 
• By Brian Bossetta

In recognition of Mental Health Awareness month, Sarah Jenkins, executive director at the National Association for Continence, discussed the mental health issues that often come with incontinence.

AI Rollout Aims To Accelerate FDA’s Product Review Process

 
• By Elizabeth Orr

The FDA plans to implement artificial intelligence in its scientific review process by 30 June, following a successful pilot. The agency hopes the tool will reduce nonproductive tasks for reviewers amid recent staff cuts. A Chief AI Officer will oversee the rollout and integration.